Hyperaldosteronism: Difference between revisions
No edit summary |
No edit summary |
||
Line 13: | Line 13: | ||
{| class="wikitable" | {| class="wikitable" | ||
! | ! rowspan="9" |Primary hyperaldosteronism | ||
! | !Category | ||
!Disease | !Disease | ||
! | ! | ||
Line 20: | Line 20: | ||
! | ! | ||
|- | |- | ||
| rowspan="2" |[[Adrenal gland|Adrenal]] causes | | rowspan="2" |[[Adrenal gland|Adrenal]] causes | ||
| | | |
Revision as of 12:45, 18 September 2017
Hyperaldosteronism Main page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
This page contains general information about Hyperaldosteronism. For more information on specific types, please visit the pages on Primary hyperaldosteronism, and Secondary hyperaldosteronism.
Synonyms and keywords: Aldosteronism
Overview
Classification
Aldosteronism and mineralocorticoid excess may be classified into two types, primary hyperaldosteronism (conn's syndrome) and secondary hyperaldosteronism. The different types of aldosteronism described in the below table:
Primary hyperaldosteronism | Category | Disease | |||
---|---|---|---|---|---|
Adrenal causes |
|
||||
|
|||||
Extra-adrenal causes |
|
||||
Familial hyperaldosteronism |
|
||||
|
|||||
|
|||||
Other |
|
||||
|
|||||
Secondary hyperaldosteronism | Genetic mutation | Bartter and Gitelman syndromes | Hyperplasia of the juxtaglomerular apparatus (the source of renin in the kidney), | ||
Liddle syndrome or pseudohypoaldosteronism type 1 | due to resistance to the actions of aldosterone | ||||
Endocrine causes | Cushing syndrome | ||||
Ectopic ACTH production | |||||
Renovascular | Kidney transplant | ||||
Renin-secreting juxtaglomerular cell tumors | |||||
Scleroderma renal crisis | |||||
Malignant hypertension | |||||
Tumors | Reninoma | ||||
Intravascular hypovolemia | heart failure, hepatic cirrhosis, and nephrotic syndrome |
Pseudohyperaldosteronism causes:
Pseudohyperaldosteronism causes | Disease | Cause | Labratory | |||||
---|---|---|---|---|---|---|---|---|
Elevated mineralocorticoid | Renin | Aldosterone | Other | Treatment | ||||
Endogenous causes | Deficiency of 17a-hydroxylase | Deoxycorticosterone (DOC) | ↓ | ↓ | ||||
11b-hydroxylase | ||||||||
Apparent mineralocorticoid excess syndrome (AME) | Genetic or acquired defect of 11-HSD | ↓ | ↓ | Urinary free cortisone ↓↓ | dexamethasone and/or MR-blockers | |||
Liddle’s syndrome | Mutation of the epithelial sodium channels (ENaC) gene in the distal renal tubules | ↓ | ↓ | amiloride or triamterene can reverse the clinical picture reactivating the renin aldosterone | ||||
Cushing’s syndrome | The main pathogenetic mechanism is linked to the excess
of cortisol which saturates 11-HSD2 activity, allowing cortisol to bind MR. A similar picture is also related to over secretion of cortisol by adrenocortical carcinomas. In some cases the disease is associated with secondary hyperaldosteronism due to a direct activation of the renin angiotensin system by glucocorticoids. |
↓ |
|
Urinary free cortisol markedly ↑↑ | ||||
Insensitivity to glucocorticoids (Chrousos syndrome) | mutations in glucocorticoid receptor (GR) gene | Deoxycorticosterone (DOC) | ↓ | ↓ | dexamethasone | |||
Aldosterone-secreting adrenocortical carcinoma | ||||||||
Geller’s syndrome | mutation of MR that alters its specificity and allows progesterone to bind MR | severe hypertension particularly during pregnancy | ↓ | ↓ | ||||
Gordon’s syndrome or pseudohypoaldosteronism type 2 | due to different mutations correlated to different phenotypes. Mutations of at least four genes have been identified, including WNK1 and WNK4 | hypertension, characterized by hyperkalemia, normal renal function | ↓ | ↓ | thiazide diuretics and/or dietary sodium restriction | |||
Exogenous causes | Corticosteroids with mineralocorticoid activity | |||||||
Hypersodic diets | ||||||||
Water intossications | ||||||||
Licorice ingestion | ↓ | ↓ | Urinary free cortisol Moderate ↑ | |||||
grapefruit | ||||||||
Contraceptives | ||||||||
Some progestins | ||||||||
Particular causes of hypertension | Sclerosis of juxtaglomerular apparatus (diabetic microangiopathy and/or of the elderly) | |||||||
FANS | ||||||||
B-Adrenergic agonists | ||||||||
Aging | ||||||||
Low-renin essential hypertension | ||||||||
Autonomic dysfunction | ||||||||
Partial/total nephrectomy or removal of renal tissue |
Differentiating Diagnosis
Hyperaldosteronism should be differentiated from other diseases causing hypertension and hypokalemia for example:
- Renal artery stenosis
- Cushing's syndrome
- Congenital adrenal hyperplasia (CAH)
- Liddle's syndrome
- Diuretic use
- Licorice ingestion
- Renin-secreting tumors
Hypertension and Hypokalemia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Plasma renin activity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal or High (Plasma Renin/Aldosterone ratio <10 | Suppressed (Plasma Renin/Aldosterone ratio >20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*Renin-secreting tumors *Diuretic use *Renovascular hypertension *Coarctation of aorta *Malignant phase hypertension | Urinary aldosterone | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Elevated | Normal | Low | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conn's syndrome (Primary aldosteronism) | Profound K+ depletion | • 17 alpha hydroxylase deficiency • 11 beta hydroxylase deficiency • Liddle's syndrome • Licorice ingestion • Deoxycortisone producing tumor | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Add Mineralocrticoid antagonist for 8 weeks | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BP response | No BP response | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
• Deoxycorticosterone excess( Tumor, 17 alpha hydroxylase and 11 beta hydroxylase deficiency) • Licorice ingestion •Glucocorticoid resistance | Liddle's syndrome) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||